Related Experiment Videos
Lymphoma associated with human immunodeficiency virus infection
Mayo Clinic Proceedings
|July 1, 1995
Summary
Human immunodeficiency virus (HIV) infection increases the risk of aggressive non-Hodgkin's lymphoma, often characterized by extranodal involvement and poor prognosis. Treatment challenges include toxicity and limited survival rates.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Malignant lymphoma in HIV-infected individuals meets acquired immunodeficiency syndrome (AIDS) diagnostic criteria.
- The incidence of HIV-related lymphoma is rising globally.
- B-cell hyperactivation is a key factor in lymphoma development.
Purpose of the Study:
- To describe lymphoma associated with human immunodeficiency virus (HIV) infection.
- To review the epidemiology, etiopathogenesis, and clinicopathologic characteristics of HIV-related lymphoma.
- To discuss therapeutic regimens and prognostic factors for HIV-related lymphoma.
Main Methods:
- Review of major studies on HIV-related lymphoma.
- Analysis of epidemiological data.
- Discussion of therapeutic regimens and prognostic factors.
Main Results:
- HIV-related lymphoma presents with high-grade malignancy, B-cell phenotype, and frequent extranodal involvement.
- Mechanisms include viral activity (HIV, Epstein-Barr virus), growth factors, and genetic alterations.
- Treatment is associated with toxicity, infectious complications, low response rates, and short survival.
Conclusions:
- Individuals with HIV-induced immune dysregulation face a high risk of aggressive non-Hodgkin's lymphoma.
- Future research should explore the role of specific viruses, antiviral treatments, and novel therapeutic strategies.